These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25703856)

  • 1. Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: a qualitative insight into the perspectives of surgeons and medical oncologists.
    van Erning FN; Janssen-Heijnen ML; Creemers GJ; Pruijt HF; Maas HA; Lemmens VE
    J Geriatr Oncol; 2015 May; 6(3):219-24. PubMed ID: 25703856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
    Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
    J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
    Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
    J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Course of Neuropathic Symptoms in Relation to Adjuvant Chemotherapy Among Elderly Patients With Stage III Colon Cancer: A Longitudinal Study.
    van Erning FN; Janssen-Heijnen MLG; Wegdam JA; Slooter GD; Wijsman JH; Vreugenhil A; Beijers TAJM; van de Poll-Franse LV; Lemmens VEPP
    Clin Colorectal Cancer; 2017 Sep; 16(3):195-203. PubMed ID: 27756521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the outcomes of adjuvant chemotherapy for colon cancer prescribed by physicians in different disciplines: a population-based study in Taiwan.
    Hsieh CI; Kuo RN; Liang CC; Tsai HY; Chung KP
    BMJ Open; 2018 Dec; 8(12):e021341. PubMed ID: 30567819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
    Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
    Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision-making under clinical uncertainty: An in-depth examination of provider perspectives on adjuvant chemotherapy for stage II colon cancer.
    Shelton RC; Brotzman LE; Crookes DM; Robles P; Neugut AI
    Patient Educ Couns; 2019 Feb; 102(2):284-290. PubMed ID: 30262401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer.
    Kirkpatrick HM; Aitelli CL; Qin H; Becerra C; Lichliter WE; McCollum AD
    Clin Colorectal Cancer; 2010 Jul; 9(3):150-6. PubMed ID: 20643619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient age and cancer treatment decisions. Patient and physician views.
    Kutner JS; Vu KO; Prindiville SA; Byers TE
    Cancer Pract; 2000; 8(3):114-9. PubMed ID: 11898135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Oncologists' Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer.
    Yu IS; Pereira AAL; Lee M; Korphaisarn K; Marshall J; Segelov E; O'Callaghan C; Lim HJ; Kopetz S; Loree JM
    Oncologist; 2020 Mar; 25(3):229-234. PubMed ID: 32162828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients.
    Becerra AZ; Aquina CT; Mohile SG; Tejani MA; Schymura MJ; Boscoe FP; Xu Z; Justiniano CF; Boodry CI; Swanger AA; Noyes K; Monson JR; Fleming FJ
    Ann Surg Oncol; 2017 Jun; 24(6):1610-1617. PubMed ID: 27738848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
    van Gils CW; Koopman M; Mol L; Redekop WK; Uyl-de Groot CA; Punt CJ
    Acta Oncol; 2012 Jan; 51(1):57-64. PubMed ID: 22122695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists.
    Moth EB; Kiely BE; Naganathan V; Martin A; Blinman P
    Support Care Cancer; 2018 Feb; 26(2):451-460. PubMed ID: 28776149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
    van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
    Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of referral for adjuvant therapy for colorectal cancer.
    Ong S; Watters JM; Grunfeld E; O'Rourke K
    Can J Surg; 2005 Jun; 48(3):225-9. PubMed ID: 16013627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status on microsatellite instability, prognosis and adjuvant therapy in colon cancer: A nationwide survey of medical oncologists, colorectal surgeons and gastrointestinal pathologists.
    Toh JWT; Mahajan H; Chapuis P; Spring K
    Cancer Rep (Hoboken); 2021 Feb; 4(1):e1297. PubMed ID: 33030308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influences of age and co-morbidities on treatment decisions for patients with HER2-positive early breast cancer.
    Ring A
    Crit Rev Oncol Hematol; 2010 Nov; 76(2):127-32. PubMed ID: 20097087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why adjuvant chemotherapy for stage III colon cancer was not given: Reasons for non-recommendation by clinicians or patient refusal.
    Gilbar P; Lee A; Pokharel K
    J Oncol Pharm Pract; 2017 Mar; 23(2):128-134. PubMed ID: 26692241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer.
    Luo R; Giordano SH; Freeman JL; Zhang D; Goodwin JS
    Oncologist; 2006 Oct; 11(9):1025-33. PubMed ID: 17030645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.
    Winget M; Hossain S; Yasui Y; Scarfe A
    Cancer; 2010 Oct; 116(20):4849-56. PubMed ID: 20578180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.